Hetvi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Months 12 Days
About Hetvi Pharmaceuticals
Hetvi Pharmaceuticals Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 May 2024 ( eight months 12 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Patel Dahyabhai, Pankajbhai Sojitra, and Alakhnarayan Tiwari serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21009GJ2024PTC151819
-
Company No.
151819
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 May 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Hetvi Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Patel Dahyabhai
|
Director | 24-May-2024 | Current |
|
Pankajbhai Sojitra
|
Director | 24-May-2024 | Current |
|
Alakhnarayan Tiwari
|
Director | 24-May-2024 | Current |
Financial Performance of Hetvi Pharmaceuticals.
Enhance accessibility to Hetvi Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hetvi Pharmaceuticals?
Unlock access to Hetvi Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pharmastra Lifecare Private LimitedPankajbhai Sojitra is a mutual person
-
Hetvi Lifesciences Private LimitedPatel Dahyabhai is a mutual person
-
Jack Cosmetics Private Limited
Pankajbhai Sojitra and Alakhnarayan Tiwari are mutual person
-
Inmedicare Private Limited
Pankajbhai Sojitra is a mutual person
-
Qxp Pharma Project And Gmp Services Private Limited
Pankajbhai Sojitra is a mutual person
-
Smirom Poly Film Private Limited
Alakhnarayan Tiwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hetvi Pharmaceuticals?
Unlock and access historical data on people associated with Hetvi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hetvi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetvi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.